Načítá se...
Naringin sensitizes human prostate cancer cells to paclitaxel therapy
BACKGROUND: The aim of the study was to evaluate whether the use of chemotherapy in combination with naringin, a dietary plant polyphenolic flavonoid, could enhance the therapeutic efficacy of paclitaxel treatment in human prostate cancer (PCa) cells. MATERIALS AND METHODS: DU145, PC3, and LNCaP cel...
Uloženo v:
| Vydáno v: | Prostate Int |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Asian Pacific Prostate Society
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6251953/ https://ncbi.nlm.nih.gov/pubmed/30505814 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.prnil.2017.11.001 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|